StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Bionano Genomics's enterprise value was $3.04M on Nov 11, 2026, against -$3.58M a year earlier. Over the last 5 years it ranged from -$31.20M to $531.87M, with a median of $8.45M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.04M–
2025Dec 31, 2025-$6.69M-149.4%
2024Dec 31, 2024$13.56M+321.7%
2023Dec 29, 2023$3.21M-98.7%
2022Dec 30, 2022$253.20M-50.9%
2021Dec 31, 2021$515.27M+13.5%
2020Dec 31, 2020$453.97M+1786.6%
2019Dec 31, 2019$24.06M-41.2%
2018Dec 31, 2018$40.91M–

More Bionano Genomics figures

See a number that looks wrong?